<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Hepat Mon</journal-id><journal-id journal-id-type="iso-abbrev">Hepat Mon</journal-id><journal-id journal-id-type="doi">10.5812/hepatmon</journal-id><journal-id journal-id-type="publisher-id">Kowsar</journal-id><journal-title-group><journal-title>Hepatitis Monthly</journal-title></journal-title-group><issn pub-type="ppub">1735-143X</issn><issn pub-type="epub">1735-3408</issn><publisher><publisher-name>Kowsar</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24976844</article-id><article-id pub-id-type="pmc">4071358</article-id><article-id pub-id-type="doi">10.5812/hepatmon.19880</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Volatile Anesthetics in Ischemic Liver Injury: Enemy or Friend?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mohseni</surname><given-names>Masood</given-names></name><xref ref-type="aff" rid="aff37948">1</xref></contrib><contrib contrib-type="author"><name><surname>Safari</surname><given-names>Saeid</given-names></name><xref ref-type="aff" rid="aff37948">1</xref><xref ref-type="aff" rid="aff37949">2</xref></contrib><contrib contrib-type="author"><name><surname>Alavian</surname><given-names>Seyed Moayed</given-names></name><xref ref-type="aff" rid="aff37949">2</xref><xref ref-type="aff" rid="aff39049">3</xref><xref ref-type="corresp" rid="cor37950">*</xref></contrib></contrib-group><aff id="aff37948"><label>1</label>Department of Anesthesiology, Iran University of Medical Sciences, Tehran, IR Iran</aff><aff id="aff37949"><label>2</label>Middle East Liver Diseases Center (MELD), Tehran, IR Iran</aff><aff id="aff39049"><label>3</label>Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran</aff><author-notes><corresp id="cor37950"><label>*</label>Corresponding Author: Seyed Moayed Alavian, Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran. Tel: +98-2188945186, Fax: +98-2188945188, E-mail: <email>alavian@thc.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2014</year></pub-date><volume>14</volume><issue>6</issue><elocation-id>e19880</elocation-id><history><date date-type="received"><day>30</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>01</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014, Kowsar Corp.; Published by Kowsar Corp.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><kwd-group kwd-group-type="author"><kwd>Anesthetics, Inhalation</kwd><kwd>Liver Diseases</kwd><kwd>Perioperative Care</kwd><kwd>Anesthesiology</kwd><kwd>Intraoperative Care</kwd></kwd-group></article-meta></front><body><p>Ischemic liver injury occurs in a variety of clinical settings such as trauma, shock, and liver surgery (<xref rid="A19880R1" ref-type="bibr">1</xref>, <xref rid="A19880R2" ref-type="bibr">2</xref>). Ischemia and subsequent reperfusion injury rapidly evolves to sinusoid endothelial cell damage, activation of Kupffer cells, inflammation, hepatocyte necrosis and finally liver dysfunction, especially in patients with preoperative liver injures (<xref rid="A19880R3" ref-type="bibr">3</xref>). Liver failure is associated with a risk of poor outcome (<xref rid="A19880R4" ref-type="bibr">4</xref>). Therefore, a judicious strategy for intraoperative physical and pharmacological liver protection should be implemented. A few decades ago, postoperative mortality following liver surgery or non-hepatic surgery in a patient with liver dysfunction was as high as 50% (<xref rid="A19880R5" ref-type="bibr">5</xref>, <xref rid="A19880R6" ref-type="bibr">6</xref>). Substantial improvement in techniques of surgery and perioperative care has made surgery dramatically safer in these patients. Better knowledge of liver pathophysiology has made perioperative liver protection feasible (<xref rid="A19880R7" ref-type="bibr">7</xref>, <xref rid="A19880R8" ref-type="bibr">8</xref>). Contribution of anesthesiologists to new horizons of safety deserves to be highlighted. High quality organ preservation during liver surgeries by hypothermia, management of intraoperative massive hemorrhage and blood transfusion, appropriate fluid management, postoperative pain control and stress reduction and recently preconditioning by using certain opioids (<xref rid="A19880R9" ref-type="bibr">9</xref>-<xref rid="A19880R11" ref-type="bibr">11</xref>) and volatile anesthetics (<xref rid="A19880R12" ref-type="bibr">12</xref>) are examples of protective strategies implemented by anesthesiologists.</p><p>Recent evidences suggest that an exposure to a brief period of ischemia or mild oxidative stress before a severe ischemic insult would help the organ to minimize the sequels of ischemia, a phenomenon known as preconditioning. Several modes of action have been proposed for preconditioning including biological adaptation to injury, direct protection by anti-inflammatory or anti-apoptotic mechanisms and finally organ priming by cellular activation of protection (e.g. hemoxygenases-1). A variety of preconditioning methods have been introduced to date such as hyperthermic, ischemic and pharmacological strategies, with variable degrees of efficacy (<xref rid="A19880R13" ref-type="bibr">13</xref>). In liver surgery, evidences for less effectiveness of ischemic preconditioning as well as the possibility of increased intraoperative blood loss due to intermittent clamping has made ischemic preconditioning a less favorable choice compared with pharmacological preconditioning (<xref rid="A19880R14" ref-type="bibr">14</xref>). Several medications have been proposed for pharmacological liver preconditioning including antioxidants, adenosine agonists, pentoxifylline, protease-inhibitors, anti-apoptotic substances, prostaglandins, matrix-metalloproteinases-inhibitors and inductors of hemoxygenases 1 (HO-1) (<xref rid="A19880R15" ref-type="bibr">15</xref>). Recent laboratory and clinical studies demonstrated a promising role for volatile conditioning (<xref rid="A19880R12" ref-type="bibr">12</xref>, <xref rid="A19880R16" ref-type="bibr">16</xref>) (<xref ref-type="fig" rid="fig11714">Figure 1</xref>). A well-designed clinical trial reported that application of sevoflurane for 30 minutes before the inflow hepatic occlusion would reduce perioperative injury to hepatocytes (<xref rid="A19880R12" ref-type="bibr">12</xref>). Interestingly, the protective effect of volatile anesthetics was most pronounced in patients with severe liver steatosis. Several mechanisms have been proposed for hepatoprotective effects of volatile agents including upregulation of HO-1 as an important element in the anti-oxidative system (<xref rid="A19880R17" ref-type="bibr">17</xref>, <xref rid="A19880R18" ref-type="bibr">18</xref>) as well as increased production of nitric oxide (NO), demonstrated by up-regulation of inflammatory NO synthase (iNOS) (<xref rid="A19880R19" ref-type="bibr">19</xref>).</p><p>Historically, it is believed that volatile anesthetics induce liver injury and impair its function. Numerous investigations have focused on hepatotoxic effects of volatile agents for half a century (<xref rid="A19880R5" ref-type="bibr">5</xref>, <xref rid="A19880R20" ref-type="bibr">20</xref>-<xref rid="A19880R22" ref-type="bibr">22</xref>). The story around hepatotoxic effects of volatile agents has come from findings of abnormal liver function tests and morbid outcomes following exposure to older agents such as halothane and enflurane. The incidence of autoimmune hepatitis following exposure to halothane is roughly 1:10000 (<xref rid="A19880R23" ref-type="bibr">23</xref>, <xref rid="A19880R24" ref-type="bibr">24</xref>). Although controversial, enflurane has been associated with postoperative liver injury (<xref rid="A19880R25" ref-type="bibr">25</xref>, <xref rid="A19880R26" ref-type="bibr">26</xref>). The pathophysiology of liver injury following exposure to halogenated anesthetics is mainly due to their metabolism to trifluoroacylated hepatic protein adducts which is a hepatotoxic compound. Concerns about decreased cardiac output and total hepatic blood flow when using volatile anesthetics have added to the problem (<xref rid="A19880R27" ref-type="bibr">27</xref>). However, newer generations of volatile agents including isoflurane, desflurane and sevoflurane are usually safe because of minimal, if any, biotransformation to trifluoroacylated and even show protective effects. </p><p>Isoflurane, an isomer of enflurane, is metabolized to a minimal degree (0.2%) and more slowly than halothane or enflurane (<xref rid="A19880R28" ref-type="bibr">28</xref>). In spite of minimal biotransformation, isoflurane is accused to be the cause of a wide spectrum of perioperative liver injuries, ranging from transaminitis to fulminant hepatic failure and death (<xref rid="A19880R29" ref-type="bibr">29</xref>-<xref rid="A19880R31" ref-type="bibr">31</xref>). Contrary to these reports, isoflurane has been shown to protect the liver against ischemia-reperfusion injuries. Laboratory and clinical studies are still underway to clarify the exact mechanism, but isoflurane has been shown to induce an upregulation of HO-1. It seems that induction of HO-1 is related to protein kinase C and phospholipase A2 independent of nitric oxide or reactive oxygen species (<xref rid="A19880R32" ref-type="bibr">32</xref>). In spite of reduced cardiac output, isoflurane also preserves hepatic blood supply, possibly due to direct vasodilatation in the hepatic vascular bed (<xref rid="A19880R33" ref-type="bibr">33</xref>).</p><p>Sevoflurane does not produce acylated protein adducts and it seems that it is at least as safe as isoflurane (<xref rid="A19880R34" ref-type="bibr">34</xref>). Laboratory examinations have shown the promising effect of sevoflurane on the ischemia-reperfusion injury, (<xref rid="A19880R35" ref-type="bibr">35</xref>) namely during liver surgery (<xref rid="A19880R12" ref-type="bibr">12</xref>).</p><p>Biotransformation of desflurane to trifluoroacylated is as low as 0.02% (<xref rid="A19880R36" ref-type="bibr">36</xref>, <xref rid="A19880R37" ref-type="bibr">37</xref>). It has been shown to better preserve hepatic blood flow than earlier generations of volatile agents such as halothane and enflurane (<xref rid="A19880R38" ref-type="bibr">38</xref>, <xref rid="A19880R39" ref-type="bibr">39</xref>). A recent clinical trial has suggested that the use of desflurane for maintenance of anesthesia for liver transplantation is associated with better outcome than total intravenous anesthesia (<xref rid="A19880R40" ref-type="bibr">40</xref>). Collectively, most of currently available volatile anesthetics have been shown to preserve hepatic blood flow and function (<xref rid="A19880R41" ref-type="bibr">41</xref>).</p><p>Liver surgery and perioperative care of patients with hepatic dysfunction is still moving toward better safety. Anesthesiologists play their role with optimal intraoperative transfusion and fluid management, pain control, stress reduction as well as judicious selection of anesthetic medications. Certain anesthetic agents such as sevoflurane and isoflurane improve hepatic perfusion and simultaneously protect the liver from ischemia-reperfusion injuries. Further research is required to confirm the hepatoprotective role of volatile agents and optimize their application in different ischemic scenarios.</p><fig id="fig11714" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Volatile Anesthetics Should be Tolerated to Protect the Liver in Ischemic Traumas</title></caption><graphic xlink:href="hepatmon-14-06-19880-g001"/></fig></body><back><ack><p>Our thanks go to Dr Mahsa Motavaf (member of the MELD) for final editing of the manuscript.</p></ack><fn-group><fn id="afn30942" fn-type="other"><p><bold>Implication for health policy/practice/research/medical education:</bold>Liver surgery and perioperative care of patients with hepatic dysfunction is still moving toward better safety. Anesthesiologists play their role with judicious selection of anesthetic medications.</p></fn><fn id="afn30943" fn-type="other"><p><bold>Authors&#x02019; Contributions:</bold>Conception and design, literature search, writing the manuscript: Masood Mohseni, Saeid Safari; scientifically revision of the manuscript: Seyed Moayed Alavian.</p></fn></fn-group><ref-list><title>References</title><ref id="A19880R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahde</surname><given-names>R</given-names></name><name><surname>Spiegel</surname><given-names>HU</given-names></name></person-group><article-title>Hepatic ischaemia-reperfusion injury from bench to bedside.</article-title><source>Br J Surg.</source><year>2010</year><volume>97</volume><issue>10</issue><fpage>1461</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1002/bjs.7176</pub-id><pub-id pub-id-type="pmid">20645395</pub-id></element-citation></ref><ref id="A19880R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrmann</surname><given-names>V</given-names></name><name><surname>Jager</surname><given-names>B</given-names></name><name><surname>Zubkova</surname><given-names>A</given-names></name><name><surname>Drolz</surname><given-names>A</given-names></name></person-group><article-title>Hypoxic hepatitis - epidemiology, pathophysiology and clinical management.</article-title><source>Wien Klin Wochenschr.</source><year>2010</year><volume>122</volume><issue>5-6</issue><fpage>129</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1007/s00508-010-1357-6</pub-id><pub-id pub-id-type="pmid">20361374</pub-id></element-citation></ref><ref id="A19880R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serracino-Inglott</surname><given-names>F</given-names></name><name><surname>Habib</surname><given-names>NA</given-names></name><name><surname>Mathie</surname><given-names>RT</given-names></name></person-group><article-title>Hepatic ischemia-reperfusion injury.</article-title><source>Am J Surg.</source><year>2001</year><volume>181</volume><issue>2</issue><fpage>160</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11425059</pub-id></element-citation></ref><ref id="A19880R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clavien</surname><given-names>PA</given-names></name><name><surname>Selzner</surname><given-names>M</given-names></name><name><surname>Rudiger</surname><given-names>HA</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name><name><surname>Kadry</surname><given-names>Z</given-names></name><name><surname>Rousson</surname><given-names>V</given-names></name><etal>et al.</etal></person-group><article-title>A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning.</article-title><source>Ann Surg.</source><year>2003</year><volume>238</volume><issue>6</issue><fpage>843</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1097/01.sla.0000098620.27623.7d</pub-id><pub-id pub-id-type="pmid">14631221</pub-id></element-citation></ref><ref id="A19880R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heidenberg</surname><given-names>WJ</given-names></name><name><surname>Torio</surname><given-names>IS</given-names></name><name><surname>Cebula</surname><given-names>J</given-names></name></person-group><article-title>Halothane hepatitis. An American disease?</article-title><source>Lancet.</source><year>1963</year><volume>1</volume><issue>7292</issue><fpage>85</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">13953338</pub-id></element-citation></ref><ref id="A19880R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>K</given-names></name><name><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>History of hepatic surgery.</article-title><source>Surg Clin North Am.</source><year>2010</year><volume>90</volume><issue>4</issue><fpage>655</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.suc.2010.04.018</pub-id><pub-id pub-id-type="pmid">20637939</pub-id></element-citation></ref><ref id="A19880R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clavien</surname><given-names>PA</given-names></name><name><surname>Petrowsky</surname><given-names>H</given-names></name><name><surname>DeOliveira</surname><given-names>ML</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name></person-group><article-title>Strategies for safer liver surgery and partial liver transplantation.</article-title><source>N Engl J Med.</source><year>2007</year><volume>356</volume><issue>15</issue><fpage>1545</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1056/NEJMra065156</pub-id><pub-id pub-id-type="pmid">17429086</pub-id></element-citation></ref><ref id="A19880R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajavi</surname><given-names>M</given-names></name><name><surname>Emami</surname><given-names>A</given-names></name><name><surname>Etezadi</surname><given-names>F</given-names></name><name><surname>Safari</surname><given-names>S</given-names></name><name><surname>Sharifi</surname><given-names>A</given-names></name><name><surname>Shariat Moharari</surname><given-names>R</given-names></name></person-group><article-title>Conscious Sedation and Analgesia in Colonoscopy: Ketamine/Propofol Combination has Superior Patient Satisfaction Versus Fentanyl/Propofol.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>208</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.5812/aapm.9653</pub-id><pub-id pub-id-type="pmid">24223364</pub-id></element-citation></ref><ref id="A19880R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>LQ</given-names></name><name><surname>Tao</surname><given-names>KM</given-names></name><name><surname>Liu</surname><given-names>YT</given-names></name><name><surname>Cheung</surname><given-names>CW</given-names></name><name><surname>Irwin</surname><given-names>MG</given-names></name><name><surname>Wong</surname><given-names>GT</given-names></name><etal>et al.</etal></person-group><article-title>Remifentanil preconditioning reduces hepatic ischemia-reperfusion injury in rats via inducible nitric oxide synthase expression.</article-title><source>Anesthesiology.</source><year>2011</year><volume>114</volume><issue>5</issue><fpage>1036</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e3182104956</pub-id><pub-id pub-id-type="pmid">21383616</pub-id></element-citation></ref><ref id="A19880R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azmude</surname><given-names>A</given-names></name><name><surname>Agha'amou</surname><given-names>S</given-names></name><name><surname>Yousefshahi</surname><given-names>F</given-names></name><name><surname>Berjis</surname><given-names>K</given-names></name><name><surname>Mirmohammad'khani</surname><given-names>M</given-names></name><name><surname>Sadaat'ahmadi</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>Pregnancy outcome using general anesthesia versus spinal anesthesia for in vitro fertilization.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>2</issue><fpage>239</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.5812/aapm.11223</pub-id><pub-id pub-id-type="pmid">24282775</pub-id></element-citation></ref><ref id="A19880R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>ZH</given-names></name></person-group><article-title>Pain management in intensive care unit patients: the role of ultra-short acting opioid: remifentanil.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>188</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.5812/aapm.10299</pub-id><pub-id pub-id-type="pmid">24223360</pub-id></element-citation></ref><ref id="A19880R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck-Schimmer</surname><given-names>B</given-names></name><name><surname>Breitenstein</surname><given-names>S</given-names></name><name><surname>Urech</surname><given-names>S</given-names></name><name><surname>De Conno</surname><given-names>E</given-names></name><name><surname>Wittlinger</surname><given-names>M</given-names></name><name><surname>Puhan</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic.</article-title><source>Ann Surg.</source><year>2008</year><volume>248</volume><issue>6</issue><fpage>909</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e31818f3dda</pub-id><pub-id pub-id-type="pmid">19092335</pub-id></element-citation></ref><ref id="A19880R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selzner</surname><given-names>N</given-names></name><name><surname>Boehnert</surname><given-names>M</given-names></name><name><surname>Selzner</surname><given-names>M</given-names></name></person-group><article-title>Preconditioning, postconditioning, and remote conditioning in solid organ transplantation: basic mechanisms and translational applications.</article-title><source>Transplant Rev (Orlando).</source><year>2012</year><volume>26</volume><issue>2</issue><fpage>115</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.trre.2011.07.003</pub-id><pub-id pub-id-type="pmid">22000660</pub-id></element-citation></ref><ref id="A19880R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurusamy</surname><given-names>KS</given-names></name><name><surname>Kumar</surname><given-names>Y</given-names></name><name><surname>Pamecha</surname><given-names>V</given-names></name><name><surname>Sharma</surname><given-names>D</given-names></name><name><surname>Davidson</surname><given-names>BR</given-names></name></person-group><article-title>Ischaemic pre-conditioning for elective liver resections performed under vascular occlusion.</article-title><source>Cochrane Database Syst Rev.</source><year>2009</year><issue>1</issue><fpage>CD007629</fpage><pub-id pub-id-type="doi">10.1002/14651858.CD007629</pub-id><pub-id pub-id-type="pmid">19160339</pub-id></element-citation></ref><ref id="A19880R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodoraki</surname><given-names>K</given-names></name><name><surname>Tympa</surname><given-names>A</given-names></name><name><surname>Karmaniolou</surname><given-names>I</given-names></name><name><surname>Tsaroucha</surname><given-names>A</given-names></name><name><surname>Arkadopoulos</surname><given-names>N</given-names></name><name><surname>Smyrniotis</surname><given-names>V</given-names></name></person-group><article-title>Ischemia/reperfusion injury in liver resection: a review of preconditioning methods.</article-title><source>Surg Today.</source><year>2011</year><volume>41</volume><issue>5</issue><fpage>620</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00595-010-4444-4</pub-id><pub-id pub-id-type="pmid">21533932</pub-id></element-citation></ref><ref id="A19880R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck-Schimmer</surname><given-names>B</given-names></name><name><surname>Breitenstein</surname><given-names>S</given-names></name><name><surname>Bonvini</surname><given-names>JM</given-names></name><name><surname>Lesurtel</surname><given-names>M</given-names></name><name><surname>Ganter</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial.</article-title><source>Ann Surg.</source><year>2012</year><volume>256</volume><issue>5</issue><fpage>837</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1097/SLA.0b013e318272df7c</pub-id><pub-id pub-id-type="pmid">23095629</pub-id></element-citation></ref><ref id="A19880R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maines</surname><given-names>MD</given-names></name></person-group><article-title>The heme oxygenase system: update 2005.</article-title><source>Antioxid Redox Signal.</source><year>2005</year><volume>7</volume><issue>11-12</issue><fpage>1761</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1089/ars.2005.7.1761</pub-id><pub-id pub-id-type="pmid">16356137</pub-id></element-citation></ref><ref id="A19880R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryter</surname><given-names>SW</given-names></name><name><surname>Alam</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>AM</given-names></name></person-group><article-title>Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications.</article-title><source>Physiol Rev.</source><year>2006</year><volume>86</volume><issue>2</issue><fpage>583</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1152/physrev.00011.2005</pub-id><pub-id pub-id-type="pmid">16601269</pub-id></element-citation></ref><ref id="A19880R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrier</surname><given-names>A</given-names></name><name><surname>Olaya</surname><given-names>N</given-names></name><name><surname>Chiappini</surname><given-names>F</given-names></name><name><surname>Roser</surname><given-names>F</given-names></name><name><surname>Scatton</surname><given-names>O</given-names></name><name><surname>Artus</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion.</article-title><source>FASEB J.</source><year>2005</year><volume>19</volume><issue>12</issue><fpage>1617</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1096/fj.04-3445com</pub-id><pub-id pub-id-type="pmid">16195370</pub-id></element-citation></ref><ref id="A19880R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habibollahi</surname><given-names>P</given-names></name><name><surname>Mahboobi</surname><given-names>N</given-names></name><name><surname>Esmaeili</surname><given-names>S</given-names></name><name><surname>Safari</surname><given-names>S</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name></person-group><article-title>Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.</article-title><source>Hepat Mon.</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>3</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">22087107</pub-id></element-citation></ref><ref id="A19880R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Rajaei</surname><given-names>S</given-names></name></person-group><article-title>The Role of Anesthetic Drugs in Liver Apoptosis.</article-title><source>Hepat Mon.</source><year>2013</year><volume>13</volume><issue>8</issue><elocation-id>e19880</elocation-id><pub-id pub-id-type="doi">10.5812/hepatmon.13162</pub-id><pub-id pub-id-type="pmid">24069040</pub-id></element-citation></ref><ref id="A19880R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahboobi</surname><given-names>N</given-names></name><name><surname>Esmaili</surname><given-names>S</given-names></name><name><surname>Safari</surname><given-names>S</given-names></name><name><surname>Habibollahi</surname><given-names>P</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name></person-group><article-title>Halothane: How should it be treated in a developing country?</article-title><source>EMHJ.</source><year>2011.</year></element-citation></ref><ref id="A19880R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gut</surname><given-names>J</given-names></name></person-group><article-title>Molecular basis of halothane hepatitis.</article-title><source>Arch Toxicol Suppl.</source><year>1998</year><volume>20</volume><fpage>3</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">9442277</pub-id></element-citation></ref><ref id="A19880R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habibollahi</surname><given-names>P</given-names></name><name><surname>Mahboobi</surname><given-names>N</given-names></name><name><surname>Esmaeili</surname><given-names>S</given-names></name><name><surname>Safari</surname><given-names>S</given-names></name><name><surname>Dabbagh</surname><given-names>A</given-names></name><name><surname>Alavian</surname><given-names>SM</given-names></name></person-group><article-title>Halothane-induced hepatitis: A forgotten issue in developing countries.</article-title><source>Hepat Mon.</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>3</fpage><pub-id pub-id-type="pmid">22087107</pub-id></element-citation></ref><ref id="A19880R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eger</surname><given-names>EI, 2nd</given-names></name><name><surname>Smuckler</surname><given-names>EA</given-names></name><name><surname>Ferrell</surname><given-names>LD</given-names></name><name><surname>Goldsmith</surname><given-names>CH</given-names></name><name><surname>Johnson</surname><given-names>BH</given-names></name></person-group><article-title>Is enflurane hepatotoxic?</article-title><source>Anesth Analg.</source><year>1986</year><volume>65</volume><issue>1</issue><fpage>21</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">3940466</pub-id></element-citation></ref><ref id="A19880R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>RH</given-names></name><name><surname>Strunin</surname><given-names>L</given-names></name></person-group><article-title>Hepatotoxicity of volatile anaesthetics.</article-title><source>Br J Anaesth.</source><year>1993</year><volume>70</volume><issue>3</issue><fpage>339</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">8471380</pub-id></element-citation></ref><ref id="A19880R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelman</surname><given-names>S</given-names></name></person-group><article-title>General anesthesia and hepatic circulation.</article-title><source>Can J Physiol Pharmacol.</source><year>1987</year><volume>65</volume><issue>8</issue><fpage>1762</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">3319112</pub-id></element-citation></ref><ref id="A19880R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holaday</surname><given-names>DA</given-names></name><name><surname>Fiserova-Bergerova</surname><given-names>V</given-names></name><name><surname>Latto</surname><given-names>IP</given-names></name><name><surname>Zumbiel</surname><given-names>MA</given-names></name></person-group><article-title>Resistance of isoflurane to biotransformation in man.</article-title><source>Anesthesiology.</source><year>1975</year><volume>43</volume><issue>3</issue><fpage>325</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">1163832</pub-id></element-citation></ref><ref id="A19880R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunza</surname><given-names>JT</given-names></name><name><surname>Pashayan</surname><given-names>AG</given-names></name></person-group><article-title>Postoperative elevation of serum transaminases following isoflurane anesthesia.</article-title><source>J Clin Anesth.</source><year>1992</year><volume>4</volume><issue>4</issue><fpage>336</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">1419017</pub-id></element-citation></ref><ref id="A19880R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brunt</surname><given-names>EM</given-names></name><name><surname>White</surname><given-names>H</given-names></name><name><surname>Marsh</surname><given-names>JW</given-names></name><name><surname>Holtmann</surname><given-names>B</given-names></name><name><surname>Peters</surname><given-names>MG</given-names></name></person-group><article-title>Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report.</article-title><source>Hepatology.</source><year>1991</year><volume>13</volume><issue>6</issue><fpage>1017</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">2050317</pub-id></element-citation></ref><ref id="A19880R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>GB</given-names></name><name><surname>O'Rourke</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>GO</given-names></name><name><surname>Beringer</surname><given-names>TR</given-names></name></person-group><article-title>Fatal hepatotoxicity after re-exposure to isoflurane: a case report and review of the literature.</article-title><source>Eur J Gastroenterol Hepatol.</source><year>2000</year><volume>12</volume><issue>8</issue><fpage>955</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10958225</pub-id></element-citation></ref><ref id="A19880R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoetzel</surname><given-names>A</given-names></name><name><surname>Leitz</surname><given-names>D</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Tritschler</surname><given-names>E</given-names></name><name><surname>Bauer</surname><given-names>I</given-names></name><name><surname>Loop</surname><given-names>T</given-names></name><etal>et al.</etal></person-group><article-title>Mechanism of hepatic heme oxygenase-1 induction by isoflurane.</article-title><source>Anesthesiology.</source><year>2006</year><volume>104</volume><issue>1</issue><fpage>101</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16394696</pub-id></element-citation></ref><ref id="A19880R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatecel</surname><given-names>C</given-names></name><name><surname>Losser</surname><given-names>MR</given-names></name><name><surname>Payen</surname><given-names>D</given-names></name></person-group><article-title>The postoperative effects of halothane versus isoflurane on hepatic artery and portal vein blood flow in humans.</article-title><source>Anesth Analg.</source><year>2003</year><volume>96</volume><issue>3</issue><fpage>740</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12598255</pub-id></element-citation></ref><ref id="A19880R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanaya</surname><given-names>N</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name><name><surname>Namiki</surname><given-names>A</given-names></name></person-group><article-title>Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance.</article-title><source>Br J Anaesth.</source><year>1995</year><volume>74</volume><issue>2</issue><fpage>164</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7696065</pub-id></element-citation></ref><ref id="A19880R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedirli</surname><given-names>N</given-names></name><name><surname>Ofluoglu</surname><given-names>E</given-names></name><name><surname>Kerem</surname><given-names>M</given-names></name><name><surname>Utebey</surname><given-names>G</given-names></name><name><surname>Alper</surname><given-names>M</given-names></name><name><surname>Yilmazer</surname><given-names>D</given-names></name><etal>et al.</etal></person-group><article-title>Hepatic energy metabolism and the differential protective effects of sevoflurane and isoflurane anesthesia in a rat hepatic ischemia-reperfusion injury model.</article-title><source>Anesth Analg.</source><year>2008</year><volume>106</volume><issue>3</issue><fpage>830</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1213/ane.0b013e3181616fc9</pub-id><pub-id pub-id-type="pmid">18292427</pub-id></element-citation></ref><ref id="A19880R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>TS</given-names></name><name><surname>Koblin</surname><given-names>DD</given-names></name><name><surname>Gruenke</surname><given-names>LD</given-names></name><name><surname>Weiskopf</surname><given-names>RB</given-names></name><name><surname>Rampil</surname><given-names>IJ</given-names></name><name><surname>Waskell</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane.</article-title><source>Anesth Analg.</source><year>1991</year><volume>73</volume><issue>2</issue><fpage>180</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1854033</pub-id></element-citation></ref><ref id="A19880R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>P</given-names></name><name><surname>Mychaskiw</surname><given-names>G</given-names></name><name><surname>Rai</surname><given-names>A</given-names></name></person-group><article-title>Desflurane versus opioid anesthesia for cardiac shunt procedures in infants with cyantoic congential heart disease.</article-title><source>Anesth Pain Med.</source><year>2013</year><volume>3</volume><issue>1</issue><fpage>191</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.5812/aapm.9511</pub-id><pub-id pub-id-type="pmid">24223361</pub-id></element-citation></ref><ref id="A19880R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartman</surname><given-names>JC</given-names></name><name><surname>Pagel</surname><given-names>PS</given-names></name><name><surname>Proctor</surname><given-names>LT</given-names></name><name><surname>Kampine</surname><given-names>JP</given-names></name><name><surname>Schmeling</surname><given-names>WT</given-names></name><name><surname>Warltier</surname><given-names>DC</given-names></name></person-group><article-title>Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.</article-title><source>Can J Anaesth.</source><year>1992</year><volume>39</volume><issue>8</issue><fpage>877</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1007/BF03008300</pub-id><pub-id pub-id-type="pmid">1288912</pub-id></element-citation></ref><ref id="A19880R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiskopf</surname><given-names>RB</given-names></name><name><surname>Eger</surname><given-names>EI, 2nd</given-names></name><name><surname>Ionescu</surname><given-names>P</given-names></name><name><surname>Yasuda</surname><given-names>N</given-names></name><name><surname>Cahalan</surname><given-names>MK</given-names></name><name><surname>Freire</surname><given-names>B</given-names></name><etal>et al.</etal></person-group><article-title>Desflurane does not produce hepatic or renal injury in human volunteers.</article-title><source>Anesth Analg.</source><year>1992</year><volume>74</volume><issue>4</issue><fpage>570</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">1554124</pub-id></element-citation></ref><ref id="A19880R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>JS</given-names></name><name><surname>Gwak</surname><given-names>MS</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>GS</given-names></name><name><surname>Kim</surname><given-names>JA</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors.</article-title><source>Liver Transpl.</source><year>2008</year><volume>14</volume><issue>8</issue><fpage>1150</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/lt.21490</pub-id><pub-id pub-id-type="pmid">18668648</pub-id></element-citation></ref><ref id="A19880R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotake</surname><given-names>Y</given-names></name></person-group><article-title>[Anesthetic protection against hepatic injury].</article-title><source>Masui.</source><year>2006</year><volume>55</volume><issue>5</issue><fpage>570</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16715911</pub-id></element-citation></ref></ref-list></back></article>